More on ARQT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+130.8% Growth)
- Ratings (8.2 Score)
- FDA

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arcutis Biotherapeutics (NQ:ARQT)
Delayed: 28.05 +0.70 (2.56%)
Prev. Close $27.35  
Open$27.62 
52 Wk High$ 
52 Wk Low$ 
Day High$28.60 
Day Low$27.54 
P/E N/A  
EPS$ 
Volume354,582 

Friends, Peers and Foes (?): MIRM, NAMS, TARS, PVLA, AMGN (more...)

Jul 17, 2026 04:07 PM Form 4 Arcutis Biotherapeutics, For: Jul 15 Filed by: Peetz Christopher
Jul 17, 2026 04:05 PM Form 3 Arcutis Biotherapeutics, For: Jul 15 Filed by: Peetz Christopher
Jul 17, 2026 04:01 PM Form 4 Arcutis Biotherapeutics, For: Jul 15 Filed by: Welgus Howard G.
Jul 16, 2026 04:25 PM Form 8-K Arcutis Biotherapeutics, For: Jul 15
Jul 16, 2026 09:00 AM Arcutis adds Mirum Pharmaceuticals CEO Chris Peetz to its board
Jul 16, 2026 09:00 AM Arcutis Expands Board of Directors with Appointment of Chris Peetz
Jul 15, 2026 04:02 PM Form 144 Arcutis Biotherapeutics, Filed by: Welgus Howard G.
Jul 15, 2026 04:00 PM Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
Jul 15, 2026 08:30 AM Attovia Therapeutics names John Smither to board of directors
Jul 15, 2026 08:30 AM Attovia Therapeutics Appoints John W. Smither to Board of Directors
View All Articles

Entities mentioned with ARQT

View All Entities